brain tumor. G96.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Conditions
Interventions
Intervention 1: patients in intervention group received 2-3 meq/kg hypertonic saline 5%. they were taken a blood sample (about 3 cc) before being administered hypertonic saline and 72 hours after the
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Supratentorial brain tumor patients without history of craniotomy New onset brain tumor Age above 18 and under 80
Exclusion criteria
Exclusion criteria: Metastatic brain tumor Renal failure ( Cr>1.5) Nephrotic syndrome Heart rate <60 Diabetes melitus Severe cardiopulmonary disorders Uncontrolled high blood pressure Age under 18 and above 80 Glasco Coma Scale under 6
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| S100B (a biomarker). Timepoint: operation day(before infusion of osmotic fluid) and 72 hours after surgery. Method of measurement: S100B mesuring with ELISA kit(Biovender). | — |
Secondary
| Measure | Time frame |
|---|---|
| Urine output (ml) during the operation. Timepoint: at the end of the operation. Method of measurement: by measuring of urine output collected in urine bag.;Bleeding volume(ml) during operation. Timepoint: at the end of the operation. Method of measurement: by measuring of bottle and used gauzes during the surgery.;Operating time. Timepoint: at the end of the operation. Method of measurement: by measuring time based on hours and minutes of start and end of operation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahsa Babaie
Tehran university of medical sciences
Outcome results
None listed